Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GASTFOX: FOLFOX vs TFOX in advanced oesophago-gastric adenocarcinoma
NCT03006432Phase 3Completed
- Sponsor
- Fédération Francophone de Cancérologie Digestive
- Start
- Dec 2016
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of docetaxel in Oesophago-Gastric Adenocarcinoma, sponsored by Fédération Francophone de Cancérologie Digestive. Started Dec 2016; status: completed.
02
Drugs
docetaxel
03
Conditions
Oesophago-Gastric Adenocarcinoma
Beyond the preview
Go deeper on NCT03006432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03006432.